| Number |
Sample # |
Block Code |
X Coordinate |
Y Coordinate |
Tumor Type |
Sex |
Age |
Other Information |
| 501 |
1 |
marker core |
0 |
0 |
Liver |
|
|
|
| 451 |
1 |
normal tissue |
1 |
1 |
adrenal |
|
|
XX-00-21B |
| 456 |
6 |
normal tissue |
1 |
2 |
breast |
|
|
XX-00-35 |
| 461 |
11 |
normal tissue |
1 |
3 |
cerebellum |
|
|
XX-00-17-1A |
| 466 |
16 |
normal tissue |
1 |
4 |
esophagus |
|
|
XX-00-24E |
| 471 |
21 |
normal tissue |
1 |
5 |
liver |
|
|
L |
| 476 |
26 |
normal tissue |
1 |
7 |
lymph node |
|
|
|
| 481 |
31 |
normal tissue |
1 |
8 |
ovary |
|
|
|
| 486 |
36 |
normal tissue |
1 |
9 |
prostate |
|
|
|
| 491 |
41 |
normal tissue |
1 |
10 |
small bowel |
|
|
|
| 496 |
46 |
normal tissue |
1 |
11 |
testis |
|
|
|
| 26 |
1 |
YY-00-0055 |
1 |
14 |
Breast Adenocarcinoma |
F |
79 |
ductal |
| 31 |
6 |
YY-00-0069 |
1 |
15 |
Breast Adenocarcinoma |
F |
76 |
ductal |
| 36 |
11 |
YY-00-0180 |
1 |
16 |
Breast Adenocarcinoma |
F |
27 |
ductal |
| 41 |
16 |
YY-00-0192 |
1 |
17 |
Breast Adenocarcinoma |
F |
53 |
ductal |
| 46 |
21 |
YY-00-0209 |
1 |
18 |
Breast Adenocarcinoma |
F |
35 |
ductal, IPOX ER positive, PR negative |
| 51 |
26 |
YY-00-0219 |
1 |
20 |
Breast Adenocarcinoma |
F |
70 |
lobular |
| 56 |
31 |
YY-00-0349 |
1 |
21 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 61 |
36 |
YY-00-0355 |
1 |
22 |
Breast Adenocarcinoma |
F |
U |
lobular with signet rings |
| 66 |
41 |
YY-01-0005 |
1 |
23 |
Breast Adenocarcinoma |
F |
36 |
ductal, met to LN, ER and PR+, c-erb-B2 3+ |
| 71 |
46 |
YY-01-0014 |
1 |
24 |
Breast Adenocarcinoma |
F |
61 |
met to LN, ER, PR and c-erbB2 negative |
| 76 |
51 |
YY-01-0069 |
1 |
26 |
Breast Adenocarcinoma |
F |
78 |
ductal and DCIS |
| 81 |
56 |
YY-01-0144 |
1 |
27 |
Breast Adenocarcinoma |
F |
U |
lobular |
| 86 |
61 |
YY-01-0152 |
1 |
28 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 91 |
66 |
YY-01-0158 |
1 |
29 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 96 |
71 |
YY-01-0166 |
1 |
30 |
Breast Adenocarcinoma |
F |
U |
ductal, S/P surg and XRT |
| 452 |
2 |
normal tissue |
2 |
1 |
adrenal |
|
|
|
| 457 |
7 |
normal tissue |
2 |
2 |
breast |
|
|
|
| 462 |
12 |
normal tissue |
2 |
3 |
cerebrum, gray matter |
|
|
XX-00-17-2A |
| 467 |
17 |
normal tissue |
2 |
4 |
esophagus |
|
|
|
| 472 |
22 |
normal tissue |
2 |
5 |
liver |
|
|
|
| 477 |
27 |
normal tissue |
2 |
7 |
lymph node |
|
|
|
| 482 |
32 |
normal tissue |
2 |
8 |
ovary |
|
|
|
| 487 |
37 |
normal tissue |
2 |
9 |
prostate |
|
|
|
| 492 |
42 |
normal tissue |
2 |
10 |
small bowel |
|
|
|
| 497 |
47 |
normal tissue |
2 |
11 |
thyroid |
|
|
|
| 27 |
2 |
YY-00-0056 |
2 |
14 |
Breast Adenocarcinoma |
F |
49 |
lobular with signet ring features |
| 32 |
7 |
YY-00-0175 |
2 |
15 |
Breast Adenocarcinoma |
F |
40 |
ductal |
| 37 |
12 |
YY-00-0181 |
2 |
16 |
Breast Adenocarcinoma |
F |
35 |
ductal |
| 42 |
17 |
YY-00-0193 |
2 |
17 |
Breast Adenocarcinoma |
F |
68 |
ductal |
| 47 |
22 |
YY-00-0210 |
2 |
18 |
Breast Adenocarcinoma |
F |
59 |
ductal |
| 52 |
27 |
YY-00-0332 |
2 |
20 |
Breast Adenocarcinoma |
F |
U |
poorly differentiated |
| 57 |
32 |
YY-00-0351 |
2 |
21 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 62 |
37 |
YY-00-0356 |
2 |
22 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 67 |
42 |
YY-01-0006 |
2 |
23 |
Breast Adenocarcinoma |
F |
51 |
ductal, ER and PR negative, c-erb-B2 3+ |
| 72 |
47 |
YY-01-0015 |
2 |
24 |
Breast Adenocarcinoma |
F |
66 |
ductal |
| 77 |
52 |
YY-01-0073 |
2 |
26 |
Breast Adenocarcinoma |
F |
63 |
ductal, ER-, PR+, c-erb-B2 - |
| 82 |
57 |
YY-01-0145 |
2 |
27 |
Breast Adenocarcinoma |
F |
U |
lobular |
| 87 |
62 |
YY-01-0153 |
2 |
28 |
Breast Adenocarcinoma |
F |
U |
ductal and DCIS |
| 92 |
67 |
YY-01-0160 |
2 |
29 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 97 |
72 |
YY-01-0167 |
2 |
30 |
Breast Adenocarcinoma |
F |
U |
ductal, ER-, PR-, c-erb-B2 -, tumor 3.1 cm |
| 453 |
3 |
normal tissue |
3 |
1 |
bladder |
|
|
XX-00-19A |
| 458 |
8 |
normal tissue |
3 |
2 |
breast |
|
|
|
| 463 |
13 |
normal tissue |
3 |
3 |
cerebrum, white matter |
|
|
XX-00-17-3A |
| 468 |
18 |
normal tissue |
3 |
4 |
heart |
|
|
XX-00-25A |
| 473 |
23 |
normal tissue |
3 |
5 |
lung |
|
|
XX-00-7 |
| 478 |
28 |
normal tissue |
3 |
7 |
mesothelium |
|
|
|
| 483 |
33 |
normal tissue |
3 |
8 |
pancreas |
|
|
XX-00-23-B |
| 488 |
38 |
normal tissue |
3 |
9 |
salivary gland |
|
|
XX-00-34-B |
| 493 |
43 |
normal tissue |
3 |
10 |
spleen |
|
|
|
| 498 |
48 |
normal tissue |
3 |
11 |
tongue |
|
|
|
| 28 |
3 |
YY-00-0063 |
3 |
14 |
Breast Adenocarcinoma |
F |
48 |
ductal |
| 33 |
8 |
YY-00-0177 |
3 |
15 |
Breast Adenocarcinoma |
F |
37 |
ductal |
| 38 |
13 |
YY-00-0186 |
3 |
16 |
Breast Adenocarcinoma |
F |
45 |
ductal |
| 43 |
18 |
YY-00-0196 |
3 |
17 |
Breast Adenocarcinoma |
F |
48 |
ductal |
| 48 |
23 |
YY-00-0211 |
3 |
18 |
Breast Adenocarcinoma |
F |
56 |
ductal |
| 53 |
28 |
YY-00-0337 |
3 |
20 |
Breast Adenocarcinoma |
F |
75 |
ductal IPOX positive ER (15%), negative PR, c-erb-B2 |
| 58 |
33 |
YY-00-0352 |
3 |
21 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 63 |
38 |
YY-00-0359 |
3 |
22 |
Breast Adenocarcinoma |
F |
67 |
ductal |
| 68 |
43 |
YY-01-0009 |
3 |
23 |
Breast Adenocarcinoma |
F |
56 |
ductal, met to LN |
| 73 |
48 |
YY-01-0064 |
3 |
24 |
Breast Adenocarcinoma |
F |
61 |
ductal, IPOX: ER +, PR, c-erbB-2 - |
| 78 |
53 |
YY-01-0074 |
3 |
26 |
Breast Adenocarcinoma |
F |
59 |
ductal |
| 83 |
58 |
YY-01-0146 |
3 |
27 |
Breast Adenocarcinoma |
F |
U |
poorly differentiate |
| 88 |
63 |
YY-01-0154 |
3 |
28 |
Breast Adenocarcinoma |
F |
U |
ductal, ER+, PR and c-erbB-2 - |
| 93 |
68 |
YY-01-0162 |
3 |
29 |
Breast Adenocarcinoma |
F |
U |
ductal, ER+, PR+, DCIS, tumor 1.8cm |
| 98 |
73 |
YY-01-0169 |
3 |
30 |
Breast Adenocarcinoma |
F |
U |
ductal with DCIS, tumor 1.9 cm |
| 454 |
4 |
normal tissue |
4 |
1 |
bladder |
|
|
|
| 459 |
9 |
normal tissue |
4 |
2 |
breast |
|
|
|
| 464 |
14 |
normal tissue |
4 |
3 |
colon |
|
|
XX-00-10B |
| 469 |
19 |
normal tissue |
4 |
4 |
kidney, cortex |
|
|
XX-00-9A |
| 474 |
24 |
normal tissue |
4 |
5 |
lung |
|
|
|
| 479 |
29 |
normal tissue |
4 |
7 |
mesothelium |
|
|
|
| 484 |
34 |
normal tissue |
4 |
8 |
peripheral nerve |
|
|
|
| 489 |
39 |
normal tissue |
4 |
9 |
skin |
|
|
|
| 494 |
44 |
normal tissue |
4 |
10 |
spleen |
|
|
|
| 499 |
49 |
normal tissue |
4 |
11 |
uterus, endometrium |
|
|
XX-00-11-C |
| 29 |
4 |
YY-00-0064 |
4 |
14 |
Breast Adenocarcinoma |
F |
60 |
ductal |
| 34 |
9 |
YY-00-0178 |
4 |
15 |
Breast Adenocarcinoma |
F |
34 |
ductal |
| 39 |
14 |
YY-00-0188 |
4 |
16 |
Breast Adenocarcinoma |
F |
69 |
ductal, IPOX ER, PR negative |
| 44 |
19 |
YY-00-0197 |
4 |
17 |
Breast Adenocarcinoma |
F |
48 |
lobular |
| 49 |
24 |
YY-00-0212 |
4 |
18 |
Breast Adenocarcinoma |
F |
71 |
ductal |
| 54 |
29 |
YY-00-0343 |
4 |
20 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 59 |
34 |
YY-00-0353 |
4 |
21 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 64 |
39 |
YY-00-0468 |
4 |
22 |
Breast Adenocarcinoma |
F |
60 |
ductal |
| 69 |
44 |
YY-01-0011 |
4 |
23 |
Breast Adenocarcinoma |
F |
74 |
ductal, ER and PR +, cerb-B2 2+ |
| 74 |
49 |
YY-01-0065 |
4 |
24 |
Breast Adenocarcinoma |
F |
50 |
ductal |
| 79 |
54 |
YY-01-0076 |
4 |
26 |
Breast Adenocarcinoma |
F |
79 |
ductal |
| 84 |
59 |
YY-01-0147 |
4 |
27 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 89 |
64 |
YY-01-0155 |
4 |
28 |
Breast Adenocarcinoma |
F |
U |
ductal, ER, PR +, c-erb-B2 - |
| 94 |
69 |
YY-01-0163 |
4 |
29 |
Breast Adenocarcinoma |
F |
U |
ductal, ER-, PR-, DICS, tumor >5 cm |
| 99 |
74 |
YY-01-0170 |
4 |
30 |
Breast Adenocarcinoma |
F |
U |
ductal, ER+, PR+, c-erb-B2-, focal DCIS, tumor 2.9 cm |
| 455 |
5 |
normal tissue |
5 |
1 |
bone marrow |
|
|
XX-00-33A |
| 460 |
10 |
normal tissue |
5 |
2 |
breast |
|
|
|
| 465 |
15 |
normal tissue |
5 |
3 |
colon |
|
|
|
| 470 |
20 |
normal tissue |
5 |
4 |
kidney, medulla |
|
|
|
| 475 |
25 |
normal tissue |
5 |
5 |
lung |
|
|
|
| 480 |
30 |
normal tissue |
5 |
7 |
muscle |
|
|
|
| 485 |
35 |
normal tissue |
5 |
8 |
placenta, membranes |
|
|
|
| 490 |
40 |
normal tissue |
5 |
9 |
skin |
|
|
|
| 495 |
45 |
normal tissue |
5 |
10 |
stomach |
|
|
|
| 500 |
50 |
normal tissue |
5 |
11 |
uterus, myometrium |
|
|
XX-00-11-C |
| 30 |
5 |
YY-00-0066 |
5 |
14 |
Breast Adenocarcinoma |
F |
62 |
poorly differentiated |
| 35 |
10 |
YY-00-0179 |
5 |
15 |
Breast Adenocarcinoma |
F |
37 |
DCIS only |
| 40 |
15 |
YY-00-0189 |
5 |
16 |
Breast Adenocarcinoma |
F |
70 |
ductal |
| 45 |
20 |
YY-00-0199 |
5 |
17 |
Breast Adenocarcinoma |
F |
62 |
ductal |
| 50 |
25 |
YY-00-0218 |
5 |
18 |
Breast Adenocarcinoma |
F |
57 |
ductal IPOX positive for ER, PR (focal) |
| 55 |
30 |
YY-00-0346 |
5 |
20 |
Breast Adenocarcinoma |
F |
U |
ductal |
| 60 |
35 |
YY-00-0354 |
5 |
21 |
Breast Adenocarcinoma |
F |
U |
lobular with signet rings |
| 65 |
40 |
YY-01-0002 |
5 |
22 |
Breast Adenocarcinoma |
F |
73 |
ductal, ER and PR +, c-erb-B2 3+ |
| 70 |
45 |
YY-01-0013 |
5 |
23 |
Breast Adenocarcinoma |
F |
52 |
ductal, ER, PR and c-erb-B2 negative |
| 75 |
50 |
YY-01-0066 |
5 |
24 |
Breast Adenocarcinoma |
F |
81 |
Lobular, ER, PR + |
| 80 |
55 |
YY-01-0078 |
5 |
26 |
Breast Adenocarcinoma |
F |
79 |
Hx prior Chemo Tx, Er-, PR- |
| 85 |
60 |
YY-01-0151 |
5 |
27 |
Breast Adenocarcinoma |
F |
U |
ductal and DCIS |
| 90 |
65 |
YY-01-0156 |
5 |
28 |
Breast Adenocarcinoma |
F |
U |
ductal, ER, PR+, c-erb-B2 - |
| 95 |
70 |
YY-01-0165 |
5 |
29 |
Breast Adenocarcinoma |
F |
U |
lobular, tumor ~0.5 cm |
| 100 |
75 |
YY-01-0171 |
5 |
30 |
Breast Adenocarcinoma |
F |
U |
lobular, ER+, PR+, c-erb_b2, tumor 4.0 cm |
| 101 |
1 |
YY-00-0029 |
7 |
14 |
Colonic Adenocarcinoma |
F |
49 |
Tubular Adenoma only |
| 106 |
6 |
YY-00-0041 |
7 |
15 |
Colonic Adenocarcinoma |
M |
67 |
|
| 111 |
11 |
YY-00-0225 |
7 |
16 |
Colonic Adenocarcinoma |
F |
77 |
|
| 116 |
16 |
YY-00-0230 |
7 |
17 |
Colonic Adenocarcinoma |
M |
90 |
|
| 121 |
21 |
YY-00-0235 |
7 |
18 |
Colonic Adenocarcinoma |
M |
73 |
|
| 126 |
26 |
YY-00-0240 |
7 |
20 |
Colonic Adenocarcinoma |
F |
58 |
|
| 131 |
31 |
YY-00-0247 |
7 |
21 |
Colonic Adenocarcinoma |
F |
76 |
|
| 136 |
36 |
YY-00-0261 |
7 |
22 |
Colonic Adenocarcinoma |
M |
U |
|
| 141 |
41 |
YY-00-0283 |
7 |
23 |
Colonic Adenocarcinoma |
M |
68 |
|
| 146 |
46 |
YY-01-0020 |
7 |
24 |
Colonic Adenocarcinoma |
F |
73 |
|
| 151 |
51 |
YY-01-0082 |
7 |
26 |
Colonic Adenocarcinoma |
F |
58 |
|
| 156 |
56 |
YY-01-0128 |
7 |
27 |
Colonic Adenocarcinoma |
U |
U |
|
| 161 |
61 |
YY-01-0133 |
7 |
28 |
Colonic Adenocarcinoma |
U |
U |
|
| 166 |
66 |
YY-01-0200 |
7 |
29 |
Colonic Adenocarcinoma |
U |
U |
|
| 171 |
71 |
YY-01-0227 |
7 |
30 |
Colonic Adenocarcinoma |
U |
U |
mucinous, with signet rings |
| 1 |
1 |
YY-00-0540 |
8 |
1 |
Brain Tumor |
U |
U |
GBM |
| 6 |
6 |
YY-00-0545 |
8 |
2 |
Brain Tumor |
U |
U |
GBM |
| 11 |
11 |
YY-00-0550 |
8 |
3 |
Brain Tumor |
U |
U |
GBM |
| 16 |
16 |
YY-00-0556 |
8 |
4 |
Brain Tumor |
U |
U |
GBM |
| 21 |
21 |
YY-00-0561 |
8 |
5 |
Brain Tumor |
U |
U |
GBM |
| 301 |
1 |
YY-00-0022 |
8 |
7 |
Melanoma |
F |
22 |
IPOX positive for s100, HMB-45 |
| 306 |
6 |
YY-00-0096 |
8 |
8 |
Melanoma |
U |
U |
|
| 311 |
11 |
YY-00-0503 |
8 |
9 |
Melanoma |
M |
49 |
|
| 316 |
16 |
YY-01-0043 |
8 |
10 |
Melanoma |
M |
50 |
|
| 321 |
21 |
YY-01-0184 |
8 |
11 |
Melanoma |
U |
U |
metastatic |
| 102 |
2 |
YY-00-0031 |
8 |
14 |
Colonic Adenocarcinoma |
F |
90 |
|
| 107 |
7 |
YY-00-0220 |
8 |
15 |
Colonic Adenocarcinoma |
U |
U |
Tubular Adenoma only |
| 112 |
12 |
YY-00-0226 |
8 |
16 |
Colonic Adenocarcinoma |
F |
86 |
|
| 117 |
17 |
YY-00-0231 |
8 |
17 |
Colonic Adenocarcinoma |
M |
72 |
|
| 122 |
22 |
YY-00-0236 |
8 |
18 |
Colonic Adenocarcinoma |
F |
88 |
|
| 127 |
27 |
YY-00-0241 |
8 |
20 |
Colonic Adenocarcinoma |
F |
55 |
|
| 132 |
32 |
YY-00-0248 |
8 |
21 |
Colonic Adenocarcinoma |
F |
72 |
|
| 137 |
37 |
YY-00-0266 |
8 |
22 |
Colonic Adenocarcinoma |
F |
44 |
|
| 142 |
42 |
YY-00-0497 |
8 |
23 |
Colonic Adenocarcinoma |
M |
49 |
|
| 147 |
47 |
YY-01-0021 |
8 |
24 |
Colonic Adenocarcinoma |
F |
54 |
|
| 152 |
52 |
YY-01-0083 |
8 |
26 |
Colonic Adenocarcinoma |
M |
54 |
|
| 157 |
57 |
YY-01-0129 |
8 |
27 |
Colonic Adenocarcinoma |
U |
U |
mucinous |
| 162 |
62 |
YY-01-0134 |
8 |
28 |
Colonic Adenocarcinoma |
U |
U |
mucinous, with signet rings |
| 167 |
67 |
YY-01-0201 |
8 |
29 |
Colonic Adenocarcinoma |
U |
U |
|
| 172 |
72 |
YY-01-0229 |
8 |
30 |
Colonic Adenocarcinoma |
M |
80 |
|
| 2 |
2 |
YY-00-0541 |
9 |
1 |
Brain Tumor |
U |
U |
GBM |
| 7 |
7 |
YY-00-0546 |
9 |
2 |
Brain Tumor |
U |
U |
GBM |
| 12 |
12 |
YY-00-0551 |
9 |
3 |
Brain Tumor |
U |
U |
GBM |
| 17 |
17 |
YY-00-0557 |
9 |
4 |
Brain Tumor |
U |
U |
GBM |
| 22 |
22 |
YY-00-0562 |
9 |
5 |
Brain Tumor |
U |
U |
GBM |
| 302 |
2 |
YY-00-0023 |
9 |
7 |
Melanoma |
F |
82 |
|
| 307 |
7 |
YY-00-0100 |
9 |
8 |
Melanoma |
F |
78 |
IPOX positive for HMB45, negative for S100 |
| 312 |
12 |
YY-00-0505 |
9 |
9 |
Melanoma |
M |
60 |
|
| 317 |
17 |
YY-01-0101 |
9 |
10 |
Melanoma |
U |
U |
|
| 322 |
22 |
YY-01-0185 |
9 |
11 |
Melanoma |
U |
U |
metastatic |
| 103 |
3 |
YY-00-0032 |
9 |
14 |
Colonic Adenocarcinoma |
F |
76 |
|
| 108 |
8 |
YY-00-0221 |
9 |
15 |
Colonic Adenocarcinoma |
U |
U |
|
| 113 |
13 |
YY-00-0227 |
9 |
16 |
Colonic Adenocarcinoma |
F |
41 |
|
| 118 |
18 |
YY-00-0232 |
9 |
17 |
Colonic Adenocarcinoma |
F |
45 |
|
| 123 |
23 |
YY-00-0237 |
9 |
18 |
Colonic Adenocarcinoma |
M |
71 |
|
| 128 |
28 |
YY-00-0242 |
9 |
20 |
Colonic Adenocarcinoma |
F |
78 |
|
| 133 |
33 |
YY-00-0249 |
9 |
21 |
Colonic Adenocarcinoma |
M |
38 |
|
| 138 |
38 |
YY-00-0268 |
9 |
22 |
Colonic Adenocarcinoma |
M |
56 |
|
| 143 |
43 |
YY-01-0016 |
9 |
23 |
Colonic Adenocarcinoma |
M |
61 |
|
| 148 |
48 |
YY-01-0022 |
9 |
24 |
Colonic Adenocarcinoma |
F |
78 |
mucinous |
| 153 |
53 |
YY-01-0085 |
9 |
26 |
Colonic Adenocarcinoma |
M |
46 |
mucinous |
| 158 |
58 |
YY-01-0130 |
9 |
27 |
Colonic Adenocarcinoma |
U |
U |
|
| 163 |
63 |
YY-01-0197 |
9 |
28 |
Colonic Adenocarcinoma |
U |
U |
|
| 168 |
68 |
YY-01-0203 |
9 |
29 |
Colonic Adenocarcinoma |
U |
U |
|
| 173 |
73 |
YY-01-0230 |
9 |
30 |
Colonic Adenocarcinoma |
M |
77 |
|
| 3 |
3 |
YY-00-0542 |
10 |
1 |
Brain Tumor |
U |
U |
GBM |
| 8 |
8 |
YY-00-0547 |
10 |
2 |
Brain Tumor |
U |
U |
GBM |
| 13 |
13 |
YY-00-0552 |
10 |
3 |
Brain Tumor |
U |
U |
GBM |
| 18 |
18 |
YY-00-0558 |
10 |
4 |
Brain Tumor |
U |
U |
GBM |
| 23 |
23 |
YY-00-0563 |
10 |
5 |
Brain Tumor |
U |
U |
GBM |
| 303 |
3 |
YY-00-0025 |
10 |
7 |
Melanoma |
M |
41 |
IPOX positive S100, melin (sp?) |
| 308 |
8 |
YY-00-0101 |
10 |
8 |
Melanoma |
M |
83 |
IPOX positive for S100, HMB45, negative for cytokeratin (unspecified),
CD3, CD20, CD30 |
| 313 |
13 |
YY-00-0506 |
10 |
9 |
Melanoma |
F |
71 |
|
| 318 |
18 |
YY-01-0102 |
10 |
10 |
Melanoma |
U |
U |
|
| 323 |
23 |
YY-01-0186 |
10 |
11 |
Melanoma |
U |
U |
metastatic |
| 104 |
4 |
YY-00-0033 |
10 |
14 |
Colonic Adenocarcinoma |
M |
87 |
|
| 109 |
9 |
YY-00-0222 |
10 |
15 |
Colonic Adenocarcinoma |
M |
39 |
|
| 114 |
14 |
YY-00-0228 |
10 |
16 |
Colonic Adenocarcinoma |
M |
54 |
|
| 119 |
19 |
YY-00-0233 |
10 |
17 |
Colonic Adenocarcinoma |
F |
76 |
liver metastasis |
| 124 |
24 |
YY-00-0238 |
10 |
18 |
Colonic Adenocarcinoma |
M |
72 |
|
| 129 |
29 |
YY-00-0245 |
10 |
20 |
Colonic Adenocarcinoma |
F |
83 |
|
| 134 |
34 |
YY-00-0251 |
10 |
21 |
Colonic Adenocarcinoma |
F |
71 |
|
| 139 |
39 |
YY-00-0273 |
10 |
22 |
Colonic Adenocarcinoma |
M |
64 |
|
| 144 |
44 |
YY-01-0017 |
10 |
23 |
Colonic Adenocarcinoma |
M |
53 |
|
| 149 |
49 |
YY-01-0023 |
10 |
24 |
Colonic Adenocarcinoma |
F |
76 |
|
| 154 |
54 |
YY-01-0126 |
10 |
26 |
Colonic Adenocarcinoma |
F |
61 |
|
| 159 |
59 |
YY-01-0131 |
10 |
27 |
Colonic Adenocarcinoma |
U |
U |
|
| 164 |
64 |
YY-01-0198 |
10 |
28 |
Colonic Adenocarcinoma |
U |
U |
|
| 169 |
69 |
YY-01-0204 |
10 |
29 |
Colonic Adenocarcinoma |
U |
U |
|
| 174 |
74 |
YY-01-0231 |
10 |
30 |
Colonic Adenocarcinoma |
M |
81 |
|
| 4 |
4 |
YY-00-0543 |
11 |
1 |
Brain Tumor |
U |
U |
GBM |
| 9 |
9 |
YY-00-0548 |
11 |
2 |
Brain Tumor |
U |
U |
GBM |
| 14 |
14 |
YY-00-0554 |
11 |
3 |
Brain Tumor |
U |
U |
GBM |
| 19 |
19 |
YY-00-0559 |
11 |
4 |
Brain Tumor |
U |
U |
GBM |
| 24 |
24 |
YY-00-0564 |
11 |
5 |
Brain Tumor |
U |
U |
GBM |
| 304 |
4 |
YY-00-0094 |
11 |
7 |
Melanoma |
M |
50 |
|
| 309 |
9 |
YY-00-0258 |
11 |
8 |
Melanoma |
M |
43 |
|
| 314 |
14 |
YY-00-0507 |
11 |
9 |
Melanoma |
F |
51 |
|
| 319 |
19 |
YY-01-0103 |
11 |
10 |
Melanoma |
U |
U |
Pos HMB45, S100, Vimentin; Neg LCA, keratin |
| 324 |
24 |
YY-01-0222 |
11 |
11 |
Melanoma |
U |
U |
metastatic |
| 105 |
5 |
YY-00-0034 |
11 |
14 |
Colonic Adenocarcinoma |
F |
67 |
|
| 110 |
10 |
YY-00-0223 |
11 |
15 |
Colonic Adenocarcinoma |
M |
37 |
|
| 115 |
15 |
YY-00-0229 |
11 |
16 |
Colonic Adenocarcinoma |
M |
51 |
|
| 120 |
20 |
YY-00-0234 |
11 |
17 |
Colonic Adenocarcinoma |
M |
81 |
|
| 125 |
25 |
YY-00-0239 |
11 |
18 |
Colonic Adenocarcinoma |
F |
61 |
|
| 130 |
30 |
YY-00-0246 |
11 |
20 |
Colonic Adenocarcinoma |
M |
52 |
|
| 135 |
35 |
YY-00-0252 |
11 |
21 |
Colonic Adenocarcinoma |
F |
69 |
|
| 140 |
40 |
YY-00-0277 |
11 |
22 |
Colonic Adenocarcinoma |
F |
51 |
|
| 145 |
45 |
YY-01-0018 |
11 |
23 |
Colonic Adenocarcinoma |
M |
70 |
|
| 150 |
50 |
YY-01-0081 |
11 |
24 |
Colonic Adenocarcinoma |
F |
65 |
|
| 155 |
55 |
YY-01-0127 |
11 |
26 |
Colonic Adenocarcinoma |
F |
54 |
|
| 160 |
60 |
YY-01-0132 |
11 |
27 |
Colonic Adenocarcinoma |
U |
U |
|
| 165 |
65 |
YY-01-0199 |
11 |
28 |
Colonic Adenocarcinoma |
U |
U |
mucinous with signet rings |
| 170 |
70 |
YY-01-0205 |
11 |
29 |
Colonic Adenocarcinoma |
U |
U |
|
| 175 |
75 |
YY-01-0232 |
11 |
30 |
Colonic Adenocarcinoma |
F |
66 |
mucinous |
| 5 |
5 |
YY-00-0544 |
12 |
1 |
Brain Tumor |
U |
U |
GBM |
| 10 |
10 |
YY-00-0549 |
12 |
2 |
Brain Tumor |
U |
U |
GBM |
| 15 |
15 |
YY-00-0555 |
12 |
3 |
Brain Tumor |
U |
U |
GBM |
| 20 |
20 |
YY-00-0560 |
12 |
4 |
Brain Tumor |
U |
U |
GBM |
| 25 |
25 |
YY-01-0113 |
12 |
5 |
Brain Tumor |
U |
U |
GBM |
| 305 |
5 |
YY-00-0095 |
12 |
7 |
Melanoma |
F |
73 |
IPOX positive for S100, HMB45, vimentin, negative for Cytokeratin (unspecified)
& CD45 |
| 310 |
10 |
YY-00-0502 |
12 |
8 |
Melanoma |
F |
73 |
|
| 315 |
15 |
YY-01-0041 |
12 |
9 |
Melanoma |
M |
35 |
|
| 320 |
20 |
YY-01-0104 |
12 |
10 |
Melanoma |
F |
39 |
|
| 325 |
25 |
YY-01-0241 |
12 |
11 |
Melanoma |
M |
82 |
metastatic to lymph node, extensive necrosis |
| 176 |
1 |
YY-00-0071 |
13 |
14 |
Lung Cancer |
F |
74 |
|
| 181 |
6 |
YY-00-0078 |
13 |
15 |
Lung Cancer |
F |
84 |
|
| 186 |
11 |
YY-00-0092 |
13 |
16 |
Lung Cancer |
F |
50 |
|
| 191 |
16 |
YY-00-0146 |
13 |
17 |
Lung Cancer |
F |
80 |
|
| 196 |
21 |
YY-00-0153 |
13 |
18 |
Lung Cancer |
M |
51 |
|
| 201 |
26 |
YY-00-0160 |
13 |
20 |
Lung Cancer |
F |
71 |
|
| 206 |
31 |
YY-00-0168 |
13 |
21 |
Lung Cancer |
M |
54 |
|
| 211 |
36 |
YY-00-0309 |
13 |
22 |
Lung Cancer |
F |
56 |
|
| 216 |
41 |
YY-00-0328 |
13 |
23 |
Lung Cancer |
M |
73 |
|
| 221 |
46 |
YY-00-0532 |
13 |
24 |
Lung Cancer |
F |
76 |
|
| 226 |
51 |
YY-01-0028 |
13 |
26 |
Lung Cancer |
M |
66 |
squamous |
| 231 |
56 |
YY-01-0090 |
13 |
27 |
Lung Cancer |
M |
68 |
squamous |
| 236 |
61 |
YY-01-0096 |
13 |
28 |
Lung Cancer |
M |
72 |
squamous |
| 241 |
66 |
YY-01-0141 |
13 |
29 |
Lung Cancer |
U |
U |
poorly differentiate |
| 246 |
71 |
YY-01-0180 |
13 |
30 |
Lung Cancer |
U |
U |
squamous |
| 251 |
1 |
YY-00-0011 |
14 |
1 |
Lymphoma |
M |
14 |
IPOX: L-26 positive |
| 256 |
6 |
YY-00-0016 |
14 |
2 |
Lymphoma |
F |
69 |
Hodgkins Lyphoma IPOX: R-S cells positive Ki-1, Leu-M1 |
| 261 |
11 |
YY-00-0045 |
14 |
3 |
Lymphoma |
M |
46 |
IPOX positive for CD20, CD45R, negative CDw75, CD3, CD43, CD45RO |
| 266 |
16 |
YY-00-0125 |
14 |
4 |
Lymphoma |
F |
79 |
Spleen, Flow Kappa restricted, B-cell lineage |
| 271 |
21 |
YY-00-0132 |
14 |
5 |
Lymphoma |
F |
37 |
IPOX positive for CD20, CD79a, CD45, negative for S100, cytokertatin,
CD15, CD3 |
| 276 |
26 |
YY-00-0295 |
14 |
7 |
Lymphoma |
F |
34 |
spleen, IPOX Positive for CD20, CD19, negative for CD5, CD23, CD10 |
| 281 |
31 |
YY-00-0301 |
14 |
8 |
Lymphoma |
M |
53 |
|
| 286 |
36 |
YY-00-0510 |
14 |
9 |
Lymphoma |
M |
11 |
Hodgkins Lymphoma |
| 291 |
41 |
YY-01-0055 |
14 |
10 |
Lymphoma |
M |
56 |
spleen, B- cell,CD20 positive |
| 296 |
46 |
YY-01-0105 |
14 |
11 |
Lymphoma |
M |
U |
|
| 177 |
2 |
YY-00-0072 |
14 |
14 |
Lung Cancer |
M |
63 |
|
| 182 |
7 |
YY-00-0080 |
14 |
15 |
Lung Cancer |
M |
67 |
|
| 187 |
12 |
YY-00-0139 |
14 |
16 |
Lung Cancer |
M |
75 |
|
| 192 |
17 |
YY-00-0149 |
14 |
17 |
Lung Cancer |
M |
61 |
|
| 197 |
22 |
YY-00-0155 |
14 |
18 |
Lung Cancer |
M |
50 |
|
| 202 |
27 |
YY-00-0161 |
14 |
20 |
Lung Cancer |
M |
65 |
|
| 207 |
32 |
YY-00-0170 |
14 |
21 |
Lung Cancer |
F |
59 |
|
| 212 |
37 |
YY-00-0312 |
14 |
22 |
Lung Cancer |
F |
66 |
|
| 217 |
42 |
YY-00-0527 |
14 |
23 |
Lung Cancer |
M |
77 |
|
| 222 |
47 |
YY-00-0534 |
14 |
24 |
Lung Cancer |
M |
75 |
|
| 227 |
52 |
YY-01-0029 |
14 |
26 |
Lung Cancer |
F |
58 |
squamous |
| 232 |
57 |
YY-01-0091 |
14 |
27 |
Lung Cancer |
M |
64 |
squamous |
| 237 |
62 |
YY-01-0135 |
14 |
28 |
Lung Cancer |
F |
64 |
adenocarcinoma |
| 242 |
67 |
YY-01-0142 |
14 |
29 |
Lung Cancer |
U |
U |
squamous |
| 247 |
72 |
YY-01-0181 |
14 |
30 |
Lung Cancer |
U |
U |
squamous |
| 252 |
2 |
YY-00-0012 |
15 |
1 |
Lymphoma |
M |
59 |
IPOX: positive for CD19, CD20, CD22, CD10, lambda |
| 257 |
7 |
YY-00-0017 |
15 |
2 |
Lymphoma |
M |
89 |
IPOX: positive for T-marker (unspecfied), CD30 |
| 262 |
12 |
YY-00-0046 |
15 |
3 |
Lymphoma |
M |
40 |
PTLD, EBV negatve, clonal by PCR, IPOX CD20 positive |
| 267 |
17 |
YY-00-0126 |
15 |
4 |
Lymphoma |
F |
74 |
Flow, positive for CD10, CD19, CD20, lambda |
| 272 |
22 |
YY-00-0134 |
15 |
5 |
Lymphoma |
M |
58 |
IPOX positive for CD19, CD20, FMC7, lambda, negative for CD5, CD23 |
| 277 |
27 |
YY-00-0297 |
15 |
7 |
Lymphoma |
M |
69 |
spleen, flow negative for CD5 and CD10 |
| 282 |
32 |
YY-00-0302 |
15 |
8 |
Lymphoma |
F |
20 |
Hodgkins Lymphoma, IPOX positive CD30, CD15, CD20 , status post treatment |
| 287 |
37 |
YY-00-0513 |
15 |
9 |
Lymphoma |
M |
59 |
IPOX positive CD5, CD20, CD23 |
| 292 |
42 |
YY-01-0056 |
15 |
10 |
Lymphoma |
F |
21 |
HD, NS |
| 297 |
47 |
YY-01-0123 |
15 |
11 |
Lymphoma |
U |
U |
SLL/CLL |
| 178 |
3 |
YY-00-0073 |
15 |
14 |
Lung Cancer |
F |
48 |
|
| 183 |
8 |
YY-00-0081 |
15 |
15 |
Lung Cancer |
M |
75 |
|
| 188 |
13 |
YY-00-0141 |
15 |
16 |
Lung Cancer |
M |
51 |
|
| 193 |
18 |
YY-00-0150 |
15 |
17 |
Lung Cancer |
U |
U |
|
| 198 |
23 |
YY-00-0156 |
15 |
18 |
Lung Cancer |
M |
64 |
|
| 203 |
28 |
YY-00-0162 |
15 |
20 |
Lung Cancer |
M |
47 |
|
| 208 |
33 |
YY-00-0172 |
15 |
21 |
Lung Cancer |
M |
62 |
|
| 213 |
38 |
YY-00-0314 |
15 |
22 |
Lung Cancer |
U |
U |
|
| 218 |
43 |
YY-00-0529 |
15 |
23 |
Lung Cancer |
F |
37 |
|
| 223 |
48 |
YY-01-0025 |
15 |
24 |
Lung Cancer |
M |
70 |
squamous |
| 228 |
53 |
YY-01-0030 |
15 |
26 |
Lung Cancer |
M |
71 |
squamous |
| 233 |
58 |
YY-01-0092 |
15 |
27 |
Lung Cancer |
M |
71 |
squamous |
| 238 |
63 |
YY-01-0136 |
15 |
28 |
Lung Cancer |
U |
U |
squamous |
| 243 |
68 |
YY-01-0175 |
15 |
29 |
Lung Cancer |
U |
U |
squamous |
| 248 |
73 |
YY-01-0182 |
15 |
30 |
Lung Cancer |
U |
U |
poorly differentiated |
| 253 |
3 |
YY-00-0013 |
16 |
1 |
Lymphoma |
F |
79 |
IPOX: positive for CD19, CD20, lambda |
| 258 |
8 |
YY-00-0018 |
16 |
2 |
Lymphoma |
M |
89 |
IPOX: positive CD4, CD13, CD30, EMA, vimentin, negative for L-26, CD43 |
| 263 |
13 |
YY-00-0047 |
16 |
3 |
Lymphoma |
M |
71 |
|
| 268 |
18 |
YY-00-0127 |
16 |
4 |
Lymphoma |
F |
81 |
IPOX positive CD20, CD10, negative CD3, cyclin D1 |
| 273 |
23 |
YY-00-0135 |
16 |
5 |
Lymphoma |
F |
39 |
IPOX positive for CD20, CD30, negative for CD3, CD15, EMA |
| 278 |
28 |
YY-00-0298 |
16 |
7 |
Lymphoma |
F |
U |
IPOX positive for CD20 |
| 283 |
33 |
YY-00-0303 |
16 |
8 |
Lymphoma |
F |
59 |
|
| 288 |
38 |
YY-01-0038 |
16 |
9 |
Lymphoma |
F |
70 |
B-cell, CD20, CD79a, CD30 pos, S-100, LeuM1, CD15 neg |
| 293 |
43 |
YY-01-0057 |
16 |
10 |
Lymphoma |
M |
69 |
Large T cell, pos CD45RO, CD30, CD3, neg for CD20, EMA , CD45R |
| 298 |
48 |
YY-01-0124 |
16 |
11 |
Lymphoma |
U |
U |
follicular |
| 179 |
4 |
YY-00-0075 |
16 |
14 |
Lung Cancer |
F |
75 |
|
| 184 |
9 |
YY-00-0082 |
16 |
15 |
Lung Cancer |
F |
64 |
|
| 189 |
14 |
YY-00-0142 |
16 |
16 |
Lung Cancer |
F |
73 |
|
| 194 |
19 |
YY-00-0151 |
16 |
17 |
Lung Cancer |
F |
40 |
|
| 199 |
24 |
YY-00-0158 |
16 |
18 |
Lung Cancer |
F |
76 |
|
| 204 |
29 |
YY-00-0163 |
16 |
20 |
Lung Cancer |
M |
75 |
|
| 209 |
34 |
YY-00-0173 |
16 |
21 |
Lung Cancer |
M |
46 |
|
| 214 |
39 |
YY-00-0316 |
16 |
22 |
Lung Cancer |
F |
72 |
|
| 219 |
44 |
YY-00-0530 |
16 |
23 |
Lung Cancer |
M |
56 |
|
| 224 |
49 |
YY-01-0026 |
16 |
24 |
Lung Cancer |
M |
68 |
squamous |
| 229 |
54 |
YY-01-0032 |
16 |
26 |
Lung Cancer |
F |
67 |
squamous |
| 234 |
59 |
YY-01-0094 |
16 |
27 |
Lung Cancer |
M |
74 |
adeno |
| 239 |
64 |
YY-01-0137 |
16 |
28 |
Lung Cancer |
U |
U |
adenocarcinoma |
| 244 |
69 |
YY-01-0176 |
16 |
29 |
Lung Cancer |
U |
U |
Bronchioloalveolar |
| 249 |
74 |
YY-01-0215 |
16 |
30 |
Lung Cancer |
F |
42 |
poorly Differentiated Ca |
| 254 |
4 |
YY-00-0014 |
17 |
1 |
Lymphoma |
U |
16 |
IPOX: positive for CD30, CD15 (focal), negative for CD20, EMA, UCHL1 |
| 259 |
9 |
YY-00-0020 |
17 |
2 |
Lymphoma |
M |
24 |
|
| 264 |
14 |
YY-00-0049 |
17 |
3 |
Lymphoma |
M |
69 |
IPOX positive for CD30, CD45RO, CD3 9weak), negative for CD20, CD45R and
EMA |
| 269 |
19 |
YY-00-0128 |
17 |
4 |
Lymphoma |
F |
34 |
Hodgkins Lymphoma, R-S cells IPOX positive for CD15, CD30, CD20(focal) |
| 274 |
24 |
YY-00-0137 |
17 |
5 |
Lymphoma |
M |
63 |
Flow positive for CD19, CD20/CD5 (coexpression) and CD23 |
| 279 |
29 |
YY-00-0299 |
17 |
7 |
Lymphoma |
M |
74 |
|
| 284 |
34 |
YY-00-0304 |
17 |
8 |
Lymphoma |
M |
37 |
Hodgkins Lymphoma IPOX positive L-26, EMA, negative for LeuM1, CD30 |
| 289 |
39 |
YY-01-0039 |
17 |
9 |
Lymphoma |
M |
39 |
spleen, flow CD2, CD3, CD56, CD16 pos, CD7 dim |
| 294 |
44 |
YY-01-0058 |
17 |
10 |
Lymphoma |
U |
U |
HD, NS, RS cells CD30 pos |
| 299 |
49 |
YY-01-0206 |
17 |
11 |
Lymphoma |
U |
U |
CD20+, bcl-2+, CD43+, CD5-, CF10-, CD23-, cyclin D1- |
| 180 |
5 |
YY-00-0077 |
17 |
14 |
Lung Cancer |
M |
78 |
|
| 185 |
10 |
YY-00-0089 |
17 |
15 |
Lung Cancer |
U |
U |
|
| 190 |
15 |
YY-00-0144 |
17 |
16 |
Lung Cancer |
F |
71 |
|
| 195 |
20 |
YY-00-0152 |
17 |
17 |
Lung Cancer |
F |
67 |
|
| 200 |
25 |
YY-00-0159 |
17 |
18 |
Lung Cancer |
M |
62 |
|
| 205 |
30 |
YY-00-0165 |
17 |
20 |
Lung Cancer |
M |
73 |
|
| 210 |
35 |
YY-00-0190 |
17 |
21 |
Lung Cancer |
F |
38 |
|
| 215 |
40 |
YY-00-0320 |
17 |
22 |
Lung Cancer |
M |
71 |
|
| 220 |
45 |
YY-00-0531 |
17 |
23 |
Lung Cancer |
M |
62 |
|
| 225 |
50 |
YY-01-0027 |
17 |
24 |
Lung Cancer |
M |
60 |
adeno, with papillary features, thyroglobulin negative |
| 230 |
55 |
YY-01-0089 |
17 |
26 |
Lung Cancer |
F |
60 |
|
| 235 |
60 |
YY-01-0095 |
17 |
27 |
Lung Cancer |
F |
43 |
squamous |
| 240 |
65 |
YY-01-0138 |
17 |
28 |
Lung Cancer |
U |
U |
squamous |
| 245 |
70 |
YY-01-0177 |
17 |
29 |
Lung Cancer |
U |
U |
poorly differentiated |
| 250 |
75 |
YY-01-0216 |
17 |
30 |
Lung Cancer |
F |
63 |
squamous, 10.5 cm |
| 255 |
5 |
YY-00-0015 |
18 |
1 |
Lymphoma |
M |
49 |
|
<
